BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18340541)

  • 1. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Hannibal CG; Jensen A; Sharif H; Kjaer SK
    Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
    Jensen A; Sharif H; Kjaer SK
    Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer risk after the use of ovulation-stimulating drugs.
    Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
    Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood tumor risk after treatment with ovulation-stimulating drugs.
    Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
    Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
    Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro fertilization and breast cancer risk: a review.
    Salhab M; Al Sarakbi W; Mokbel K
    Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk associated with ovulation-stimulating drugs.
    Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
    Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study.
    Gauthier E; Paoletti X; Clavel-Chapelon F;
    Hum Reprod; 2004 Oct; 19(10):2216-21. PubMed ID: 15271872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine cancer after use of clomiphene citrate to induce ovulation.
    Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
    Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
    Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
    Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of ovarian cancer after treatment for infertility.
    Bristow RE; Karlan BY
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):32-7. PubMed ID: 8777256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
    Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
    Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
    Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
    Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive history and cutaneous malignant melanoma: a comparison between women and men.
    Kaae J; Andersen A; Boyd HA; Wohlfahrt J; Melbye M
    Am J Epidemiol; 2007 Jun; 165(11):1265-70. PubMed ID: 17327217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study.
    Kotsopoulos J; Librach CL; Lubinski J; Gronwald J; Kim-Sing C; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Randall S; Manoukian S; Pasini B; Tung N; Ainsworth PJ; Cummings S; Sun P; Narod SA;
    Cancer Causes Control; 2008 Dec; 19(10):1111-9. PubMed ID: 18509731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women.
    Jensen A; Sharif H; Olsen JH; Kjaer SK
    Am J Epidemiol; 2008 Jul; 168(1):49-57. PubMed ID: 18448441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanning bed exposure increases the risk of malignant melanoma.
    Ting W; Schultz K; Cac NN; Peterson M; Walling HW
    Int J Dermatol; 2007 Dec; 46(12):1253-7. PubMed ID: 18173518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.